Drug Shortage Report for VIOKACE
| Report ID | 62330 |
| Drug Identification Number | 02241933 |
| Brand name | VIOKACE |
| Common or Proper name | Viokace |
| Company Name | NESTLE ENTERPRISES S.A. |
| Market Status | MARKETED |
| Active Ingredient(s) | AMYLASE PROTEASE LIPASE |
| Strength(s) | 113400UNIT 112500UNIT 20880UNIT |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 count bottle |
| ATC code | A09AA |
| ATC description | DIGESTIVES, INCL ENZYMES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2018-08-27 |
| Estimated end date | 2018-10-12 |
| Actual end date | 2016-10-05 |
| Shortage status | Avoided shortage |
| Updated date | 2018-10-09 |
| Company comments | Production delay |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 12, RUE ENTRE-DEUX-VILLES VEVEY, -- SWITZERLAND 1800 |
| Company contact information | kfeltmate@apcipharma.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2018-10-09 | French | Compare |
| v3 | 2018-10-09 | English | Compare |
| v2 | 2018-09-25 | French | Compare |
| v1 | 2018-09-25 | English | Compare |
Showing 1 to 4 of 4